Default: Experimental Hematology

ISSN: 0301-472X

Journal Home

Journal Guideline

Experimental Hematology Q1 Unclaimed

Elsevier Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Experimental Hematology is a journal indexed in SJR in Cell Biology and Molecular Biology with an H index of 129. It has an SJR impact factor of 1,157 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,157.

Experimental Hematology focuses its scope in these topics and keywords: hematopoietic, marrow, bone, control, transcription, cells, stem, factor, cell, fusion, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -


- €

Inmediate OA


Embargoed OA

0 €

Non OA


Experimental Hematology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

hematopoietic, marrow, bone, control, transcription, cells, stem, factor, cell, fusion, formation, integrinmediated, human, increased, increases, inhibitors, expression, evolving, efficiently, alltransretinoic, amleto, autophagy, cellsleukemogenic, circulating, component, cytochrome, datainduction, differentiation, differentiationcytoskeleton, diphosphate,

Best articles by citations

Effect of combined INTERLEUKIN-1-alpha (IL1-A), Cyclophosphamide (Ctx) Treatment on hematopoietic stem cell function and numbers

View more

Gene transfer to ankyrin-deficient bone marrow corrects spherocytosis in vitro

View more

The influence of different cryopreservation protocols on the recovery and engraftment potential of hematopoietic stem and progenitor cells.

View more

Improved blood hematopoietic progenitor mobilization in myeloma patients following treatment with thalidomide

View more

Cml patients with advanced phase disease retain clonogenic progenitor cells which are responsive to interferon alfa and STI571 in vitro

View more

Immune responses of m-csf-r dna vaccine and its effects on hematopoiesis in mice

View more

Ex vivo expansion of cord blood megakaryocytic cells

View more

In vivo hematopoietic potential of human neuronal stem cells

View more

Tristetraprolin is a regulator of granulocyte-macrophage colony-stimulating factor mRNA stability

View more

All-trans-retinoic acid inhibits the erythroid differentiation program of human marrow CD34+ progenitors

View more

PI3-Kinase may be involved in cml progenitor cell responses to interferon alfa and STI571

View more

Residual erythroid progenitors present in w/w mice respond to erythropoietin in the absence of steel factor signals

View more

Effects of anti-oxidants on normal and leukemic hematopoiesis

View more

Genetic analysis of denritic cell and macrophage differentiation from myb-transformed myeloid cell lines

View more

Feasibility and recent improvement of autologous stem cell transplantation for acute myelocytic leukemia in patients over 60 years of age

View more

Identification of a 85.0/124.5 kd molecule with anti-homoaggregation activity on KG1a cell surface by a single chain antibody from a phage display library

View more

GATA-1 Low mice respond more readily than their normal littermates to in vivo perturbations of erythropoiesis

View more

Long-term, drug-dependent regulation of erythropoietin and hematocrit in mice following delivery of plasmids to skeletal muscle

View more

Some evidences for an intracrine loop in the macrophage colony-stimulating factor (M-csf) System

View more

Paroxysmal nocturnal hemoglobinuria Differential gene expression of EGR-1 and TAXREB107

View more

SOCS3 Plays an important negative regulatory role in myeloid colony formation

View more

Mechanism of benzene toxicity and leukemo-genicity

View more

We Welcome a New Associate Editor

View more

Cocultivation of umbilical cord blood cells with endothelial cells leads to extensive amplification of competent CD34+CD38- cells

View more